As of 2025-05-24, the Fair Value of Collplant Biotechnologies Ltd (CLGN) is -7.25 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.93 USD, the upside of Collplant Biotechnologies Ltd is -475.80%.
With the market price of 1.93 USD and our fair value calculation, Collplant Biotechnologies Ltd (CLGN) is not a good investment. Investing in CLGN stocks now will result in a potential loss of 475.80%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -5.77 | 0.24 | -16.93 | -7.02 | -16.61 | -9.22 |
| YoY growth | 48.30% | 104.16% | -7,154.17% | 58.54% | -136.63% | -1,415.96% |
| Market Cap (mil) | 22.10 |
| P/E | |
| Forward P/E |
| EPS | -1.45 |
| Avg earnings growth rate | -1,415.96% |
| TTM earnings | -16.61 |